Evidence item

City of Hope reports roughly 87% stage I–II detection with 3% and 16% false-positive rates in low- and high-risk groups. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 14201

Source: New Study: Blood Test Shows Promise for Detecting Pancreatic Cancer at Its Earliest Stages · locator {} · excerpt hash sha256:94e532afdd43cfddb939dfca039b6e14b2863a16435ff22fda619ebaad8d3e87

Exact excerpt

For the new study, published in Nature Medicine, researchers tested the liquid biopsy in nearly 1,800 patients across the United States, Europe and Asia to determine whether its previously reported promising results would hold up in diverse clinical settings. Results were very encouraging. The blood test correctly identified stage 1 and 2 pancreatic cancer 87% of the time, while its false-positive rate was just 3% in low-risk groups, and 16% in high-risk groups.

Linked claims

Claim	Direction	Relevance	Steps	Counted
ff28a421	SUPPORT	STRONG	0	yes

Audits

None.